ÖÐÎÄÃû³Æ£º Íÿ¹MTARC1¶à¿Ë¡¿¹Ìå
Ó¢ÎÄÃû³Æ£º Anti-MTARC1 rabbit polyclonal antibody
±ð Ãû£º mitochondrial amidoxime reducing component 1; MARC
Ïà¹ØÀà±ð£º Ò»¿¹
´¢ ´æ£º Àä¶³£¨-20¡æ£©
ËÞ Ö÷£º Rabbit
¿¹ Ô£º MTARC1
·´Ó¦ÖÖÊô£º Human
±ê ¼Ç Î Unconjugate
¿Ë¡ÀàÐÍ£º rabbit polyclonal
¼¼Êõ¹æ¸ñ
|
Background: |
As a component of an N-hydroxylated prodrug-converting complex required to reduce N-hydroxylated prodrugs, such as benzamidoxime. Also able to reduce N(omega)-hydroxy-L-arginine (NOHA) and N(omega)-hydroxy-N(delta)-methyl-L-arginine (NHAM) into L-arginine and N(delta)-methyl-L-arginine, respectively. |
|
Applications: |
ELISA, WB, IHC |
|
Name of antibody: |
MTARC1 |
|
Immunogen: |
Synthetic peptide of human MTARC1 |
|
Full name: |
mitochondrial amidoxime reducing component 1 |
|
Synonyms: |
MARC1; MOSC1 |
|
SwissProt: |
Q5VT66 |
|
IHC positive control: |
Human gasrtic cancer and Human thyroid cancer |
|
IHC Recommend dilution: |
50-200 |
|
WB Predicted band size: |
37 kDa |
|
WB Positive control: |
Human normal liver tissue |
|
WB Recommended dilution: |
200-1000 |


¹ºÎï³µ
°ïÖú
021-54845833/15800441009
